Development of a novel 3-month drug releasing risperidone microspheres | Zendy

Jithan Aukunuru | Zendy; Bhanusree Yerragunta | Zendy; Satheesh Jogala | Zendy; Krishna Mohan Chinnala | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Development of a novel 3-month drug releasing risperidone microspheres

Author(s) -

Jithan Aukunuru,

Bhanusree Yerragunta,

Satheesh Jogala,

Krishna Mohan Chinnala

Publication year - 2015

Publication title -

journal of pharmacy and bioallied sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.268

H-Index - 36

eISSN - 0976-4879

pISSN - 0975-7406

DOI - 10.4103/0975-7406.148777

Subject(s) - materials science , in vivo , polymer , drug , differential scanning calorimetry , microsphere , biomedical engineering , dosage form , chemical engineering , pharmacology , chromatography , nanotechnology , chemistry , composite material , medicine , microbiology and biotechnology , physics , engineering , biology , thermodynamics

The purpose of this study was to develop an ideal microsphere formulation of risperidone that would prolong the drug release for 3 months in vivo and avoid the need for co-administration of oral tablets.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research